DJIA 16,708.24 246.92 1.50%
NASDAQ 4,455.68 72.84 1.66%
S&P 500 1,956.14 29.03 1.51%
market minute promo


53.43 1.99 (3.87%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

CLVS $53.43 3.87%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $52.16
Previous Close $51.44
Daily Range $51.95 - $54.54
52-Week Range $35.33 - $93.33
Market Cap $1.8B
P/E Ratio -14.49
Dividend (Yield) $0.00 (0.0%)
Volume 440,324
Average Daily Volume 837,830
Current FY EPS -$4.20




Clovis Oncology Inc. is a biopharmaceutical company focused on acquiring developing and commercializing innovative anti-cancer agents in the United States Europe and additional international markets. Website:

News & Commentary Rss Feed

3 Beaten Down Biotech Stocks to Buy Now

The share prices of Dynavax Technologies, CellDex Therapeutics, and Clovis Oncology have all plunged this year. Here is why I think these beaten down biotechs are now compelling buys.

Clovis Oncology (CLVS) Soars: Stock Adds 13.2% is Session - Tale of the Tape

Big News for These 5 Stocks From ESMO

But smaller biotechs Clovis Oncology and Exelixis also benefit from the big boys' data.

3 Unusual-Volume Stocks Triggering Breakout Trades

Clovis Shares Higher on Improved Outlook for Lung Cancer Drug

Clovis Oncology (CLVS) CEO Pat Mahaffy Presents at Morgan Stanley Healthcare Conference (Transcript)

Clovis Oncology (CLVS) Falls: Stock Goes Down 6.8% - Tale of the Tape

CLVS January 2016 Options Begin Trading

Sector Update: Health-Care Stocks Mixed Pre-Market

Competition And Momentum Weighing On Clovis Oncology

See More CLVS News...